The recent report available at Orbis Research on "Global Phage Therapy Market" serves a comprehensive and extensive analysis towards the changing dynamics and advanced looking prospect on various factors driving or constraining industry development.
Dallas, United States - August 8, 2019 /MarketersMedia/ —
Scope of the Report:
The report titled “Global Phage Therapy Market: Size, Trends & Forecasts (2019 Edition)” presents an analysis of the global phage market in terms of value. This is followed by a market opportunity analysis of phage therapy in diseases such as Bacteremia and HAP, VAP and CF Pneumonia. The report also includes the analysis of different phages such as AP-SA01 and AP-PA02 in terms of value for the US region.
Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/3509943
Under competitive landscape, players in the phage industry have been compared on the basis of various parameters such as the phage product offered, modification, target, indication and scheduled/ expected time of clinical trial of the particular phage.
Armata Pharmaceuticals Inc., Intralytix Inc., Adaptive Phage Therapeutics Inc., Pherecydes Pharma and Locus Biosciences Inc. are some of the major players operating in the global phage therapy market whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and the business strategies of the companies are provided.
Regional Coverage:
• The US
Company Coverage:
• Armata Pharmaceuticals Inc.
• Intralytix Inc.
• Adaptive Phage Therapeutics Inc.
• Pherecydes Pharma
• Locus Biosciences Inc.
Access full report @ https://www.orbisresearch.com/reports/index/global-phage-therapy-market-size-trends-and-forecasts-2019-edition
Executive Summary:
A phage (also known as bacteriophages) are viruses that are engineered with the aim to infect bacteria and neutralize them through mechanisms that happen to be very different from those of antibiotics. Phage therapy is the therapeutic use of these phages for the treatment of pathogenic bacterial infections such as pneumonia and bacteremia.
The global phage therapy market can be segmented on the basis of mode of administration and application. On the basis of mode of administration, the market can be split into oral, rectal, local (skin, eye, ear, nasal mucosa etc.) in tampons, rinses and creams and intravenous. On the basis of application, the market can be sub segmented into human medicine, dentistry, veterinary science, and agriculture.
The global phage therapy market possesses significant opportunities in the treatment of diseases like Bacteremia and Pneumonia. The growth of the phage therapy market is supported by various growth drivers such as considerable spike in antibiotic resistance, improving regulatory scenario, demonstration of improved efficacy and excellent safety profile. Tackling material disruption of targeted phage therapies and bacteriophage product candidates in the event of security breeches is a major challenge for the players operating within the market.
Phage product launch in pipeline such as AP-SA01 (cocktail of three natural (unmodified) lytic phages developed for the treatment of S. aureus Bacteremia (SAB) blood stream infection) and AP-PA02 (cocktail of four genetically-modified/synthetic phages specific for Pseudomonas aeruginos focusing on the treatment of hospital-acquired/ventilator-associated Pneumonia (HAP/VAP) and/or cystic fibrosis (CF) Pneumonia), phage endolysins, technological advancements, fresh research on revival of phage therapy for the treatment of Cholera and bacteriophage T4 nanoparticle based dual vaccine are some of the latest trends existing in the market that have been captured in this report.
Make an enquiry of this report @ https://www.orbisresearch.com/contacts/enquiry-before-buying/3509943
Major Points from Table of Content:
1. Executive Summary
2. Introduction
3. Global Phage Market Analysis
4. Global Phage Therapy Market Analysis
5. The US Phage Therapy Market Analysis
6. Market Dynamics
7. Competitive Landscape
8. Company Profiles
Some Points from List of Figures and Tables:
Figure 1: Global Phage Therapy Market Segments
Figure 2: Global Phage Market by Value; 2017-2018 (US$ Million)
Figure 3: Global Phage Market by Value; 2019-2023 (US$ Million)
Figure 4: The US AP-SA01 Phage Market for Bacteremia by Value; 2025-2030 (US$ Million)
Figure 5: The US AP-PA02 Phage Market for HAP/VAP by Value; 2025-2030 (US$ Million)
Figure 6: The US AP-PA02 Phage Market for CF Patients by Value; 2025-2030 (US$ Million)
Figure 7: Armata Pharmaceuticals Revenues 2014-2018 (US$ Thousands)
Table 1: Phages Versus Antibiotics
Table 2: Limitations of Phage Therapy and Its Addressal
Table 3: Phage Therapy Market on the Basis of Applications
Table 4: Phage Product in Pipeline
Table 5: Therapeutic Phage Industry- Clinical Stage Phage Companies
Table 6: Therapeutic Phage Industry- Preclinical Stage Phage Companies
Table 7: Therapeutic Phage Industry-Phage Endolysins
Table 8: Intralytix Bacteriophage Product Portfolio
Buy this report @ https://www.orbisresearch.com/contact/purchase-single-user/3509943
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600
Phone: +1 (214) 884-6817
Website: https://www.orbisresearch.com/reports/index/global-phage-therapy-market-size-trends-and-forecasts-2019-edition
Source: MarketersMedia
Release ID: 88905920
